Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Harnessing CD8+CD28− regulatory T cells as a tool to treat autoimmune disease

Ceeraz, Sabrina, Thompson, Charlotte R., Beatson, Richard and Choy, Ernest H. 2021. Harnessing CD8+CD28− regulatory T cells as a tool to treat autoimmune disease. Cells 10 (11) , 2973. 10.3390/cells10112973

[thumbnail of HARNESSING CD8+CD28.pdf]
PDF - Published Version
Available under License Creative Commons Attribution.

Download (749kB) | Preview


T regulatory cell therapy presents a novel therapeutic strategy for patients with autoimmune diseases or who are undergoing transplantation. At present, the CD4+ Treg population has been extensively characterized, as a result of defined phenotypic and functional readouts. In this review article, we discuss the development and biology of CD8+ Tregs and their role in murine and human disease indications. A subset of CD8+ Tregs that lack the surface expression of CD28 (CD8+CD28− Treg) has proved efficacious in preclinical models. CD8+CD28− Tregs are present in healthy individuals, but their impaired functionality in disease renders them less effective in mediating immunosuppression. We primarily focus on harnessing CD8+ Treg cell therapy in the clinic to support current treatment for patients with autoimmune or inflammatory conditions.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Additional Information: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// 4.0/).
Publisher: MDPI
ISSN: 2073-4409
Date of First Compliant Deposit: 26 January 2022
Date of Acceptance: 28 October 2021
Last Modified: 01 Feb 2022 12:30

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics